2025 |
Viridian Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Oruka Therapeutics Inc.
|
Independent Director |
19.2 K |
- |
2024 |
Viridian Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Apogee Therapeutics Inc.
|
Independent Director |
- |
- |
2024 |
Spyre Therapeutics Inc.
|
Independent Director |
- |
- |
2024 |
Cogent Biosciences Inc
|
Chairman of the Board |
- |
- |
2023 |
Apogee Therapeutics Inc.
|
Independent Director |
668.6 K |
- |
2023 |
Viridian Therapeutics Inc
|
Independent Director |
471.8 K |
179.5 % |
2023 |
Cogent Biosciences Inc
|
Chairman of the Board |
- |
- |
2023 |
Spyre Therapeutics Inc.
|
Director |
- |
- |
2023 |
Oruka Therapeutics Inc.
|
Independent Director |
- |
- |
2023 |
Aeglea BioTherapeutics Inc
|
Director |
- |
- |
2022 |
Viridian Therapeutics Inc
|
Independent Director |
168.8 K |
-73.0 % |
2022 |
Apogee Therapeutics Inc.
|
Chairman of the Board |
- |
- |
2022 |
Cogent Biosciences Inc
|
Chairman of the Board |
- |
- |
2021 |
Viridian Therapeutics Inc
|
Independent Director |
626.3 K |
2767.8 % |
2021 |
Cogent Biosciences Inc
|
Chairman of the Board |
433.4 K |
366.3 % |
2020 |
Cogent Biosciences Inc
|
Chairman of the Board |
92.9 K |
- |
2020 |
Viridian Therapeutics Inc
|
Director |
21.8 K |
- |